The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot

BJU Int. 2021 Feb;127(2):179-181. doi: 10.1111/bju.15287. Epub 2020 Nov 16.

Sarah Spencer-Bowdage¹, Beth Russell², Jeannie Rigby¹, Jackie O'Kelly¹, Phil Kelly¹, Mark Page¹, Caroline Raw¹, Paula Allchorne^{1

3}, Peter Harper^{1

4}, Jeremy Crew^{1

5}, Roger Kockelbergh^{1

6

7}, Allen Knight^{1

8}, Mieke Van Hemelrijck², Richard T Bryan^{1

9}

¹ Action Bladder Cancer UK, Tetbury, UK.
² Translational Oncology and Urology Research, King's College London, London, UK.
³ Barts Health NHS Trust, London, UK.
⁴ Leaders in Oncology Care, London, UK.
⁵ Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁶ University Hospitals of Leicester NHS Trust, Leicester, UK.
⁷ Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
⁸ World Bladder Cancer Patient Coalition, Brussels, Belgium.
⁹ Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

No abstract available

MeSH terms